Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
08/2010
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010CA2603274C Tetracyclic compounds, their preparation process and the pharmaceutical compounds containing them
08/26/2010WO2010095765A1 Ring compound
08/26/2010WO2010095602A1 Heterocyclic compound
08/26/2010WO2010011964A3 Imaging agents useful for identifying ad pathology
08/26/2010WO2009098448A8 Compounds
08/26/2010US20100217005 Epoxy compound and method for manufacturing the same
08/26/2010US20100216821 Benzimidazoles With A Hetero Spiro-Decane Residue As NPY-Y5 Antagonists
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/25/2010EP2221303A1 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
08/25/2010EP2221302A1 Pyrido-oxazine-based monomer, polymer thereof, electrode for fuel cell including the polymer, electrolyte membrane for fuel cell including the polymer, and fuel cell using the electrode
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2219453A1 Quinoxaline-containing compounds as hepatitis c virus inhibitors
08/25/2010EP1366016B1 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN101812078A Heterocyclic dihydropyridine compound and synthesis method thereof
08/25/2010CN101812074A Method for preparing antofloxacin hydrochloride
08/25/2010CN101812063A Alpha-naphthalenesulfonamide base quintuple heterocyclic compound and anti-tumor activity thereof
08/24/2010US7781454 Substituted indazoles, benzotriazoles, and related bicyclic compounds; HIV (human immunodeficiency virus) reverse transcriptase inhibitors; delays onset of AIDS or AIDS related complex
08/24/2010US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
08/24/2010US7781446 renal cancer; after standard chemotherapy; rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779)
08/19/2010WO2010093341A1 C-7 isoxazolinyl quinolone/naphthyridine derivatives useful as antibacterial agents
08/19/2010WO2010092181A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010US20100210762 Heterocyclic compound, ultraviolet absorbent and composition containing the same
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/18/2010EP2218722A2 Process for producing benzoxazine derivative and production intermediate thereof
08/18/2010EP2217650A2 Curable benzoxazine-based compositions, their preparation and cured products thereof
08/18/2010EP2217605A1 Compounds for inhibiting ksp kinesin activity
08/18/2010EP2217604A1 Gamma secretase modulators
08/18/2010EP2217600A2 Fungicidal bicyclic pyrazoles
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217071A1 Antifungal agents
08/18/2010EP2066677B1 Pyridooxazepine progesteron receptor modulators
08/18/2010EP1940828B1 Heterocyclic aspartyl protease inhibitors
08/18/2010CN101809019A Gamma secretase modulators
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101805748A 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc
08/18/2010CN101805358A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in treatment of type 2 diabetes
08/18/2010CN101381372B Pazufloxacin mesylate and preparation method of powder for injection
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/12/2010WO2010090341A1 Method of manufacturing optically active trans-4-aminopiperidine-3-ol compound
08/12/2010WO2010089127A1 Substituted spiro-amides as b1r modulators
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010WO2009082437A9 Selective androgen receptor modulators (sarms) and uses thereof
08/12/2010US20100204466 One pot synthesis of tetrazole derivatives of rapamycin
08/12/2010US20100204216 PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-beta PROTEIN ACCUMULATION
08/12/2010US20100204201 Hiv integrase inhibitors
08/12/2010US20100204197 Pyrrolopyrimidines
08/12/2010US20100204119 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5h)-yl phenyl derivatives
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010CA2751535A1 Substituted spiro-amides as b1r modulators
08/11/2010EP2215090A1 Purine derivatives useful as pi3 kinase inhibitors
08/11/2010EP1797099B1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
08/11/2010CN1649551B Drug-delivery endovascular stent and method for treating restenosis
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772232 Quinazolinyl compounds as inhibitors of potassium channel function
08/10/2010US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/10/2010US7772228 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
08/10/2010US7772227 such as (R)-3-Cyclohexyl-2,3-dihydro-6-(4-ethylpiperazin-1-ylcarbonyl)pyrrolo[1,2,3-de]-1,4-benzoxazine hydrochloride salt, used as analgesics for the treatment of post-operative pain, chronic pain neuropathic pain, cancer pain and spasticity associated with multiple sclerosis
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/05/2010WO2010086820A1 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010US20100197909 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in subtituent at 14-position
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
08/05/2010US20100197679 Compounds
08/05/2010US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
08/05/2010US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/04/2010EP2213675A1 Pyridooxazepine derivative and use thereof
08/04/2010EP1578705B1 Medical devices containing rapamycin analogs
08/04/2010CN101792452A Preparation method of high-purity antofloxacin hydrochloride
08/03/2010US7767823 washing, crystallizing
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767663 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
08/03/2010US7767662 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents
08/03/2010CA2204748C Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation
07/2010
07/29/2010WO2010085684A1 Compositions and methods for inhibition of the jak pathway
07/29/2010WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010WO2010084501A1 A method for determination of sirolimus stability and process for preparing its stable form
07/29/2010WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases
07/29/2010US20100190804 Macrocyclic compounds and their use as kinase inhibitors
07/29/2010US20100190786 Indolin-2-ones and aza-indolin-2-ones
07/29/2010US20100190768 Novel fused pyrole derivative
07/29/2010US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010US20100190745 Heterocyclic urea derivatives and methods of use thereof
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 220